Fields of Research

Health economics
Health services and systems
Epidemiology
Central nervous system
Neurology and neuromuscular diseases
Respiratory diseases
Aged health care
Cardiology (incl. cardiovascular diseases)
Rheumatology and arthritis
Health promotion
Health informatics and information systems
Endocrinology
Health and community services
Public health
Health care administration
Residential client care
Primary health care
Paediatrics
Clinical sciences
Gastroenterology and hepatology
Traditional, complementary and integrative medicine
Nephrology and urology
Environmental epidemiology
Cardiovascular medicine and haematology
Mental health services
Aged care nursing
Aboriginal and Torres Strait Islander public health and wellbeing
Disease surveillance
Surgery
Preventative health care
Autonomic nervous system
Health policy
Health psychology
Behavioural epidemiology
Occupational and workplace health and safety
Paramedicine
Medicine, nursing and health curriculum and pedagogy
Climate change processes
Infectious diseases
Ecosystem function
Geriatrics and gerontology
Haematology
Pain
Medical biochemistry - amino acids and metabolites
Social determinants of health
Environment policy
Applied sociology, program evaluation and social impact assessment
Sports medicine
Sociology
Physiotherapy
Health systems
Exercise physiology
Epidemiological modelling
Anaesthesiology
Community and primary care
Cancer genetics
Nursing
Clinical pharmacy and pharmacy practice
Architectural science and technology
Implementation science and evaluation
Aboriginal and Torres Strait Islander and disability
Rehabilitation
Community child health
Social epidemiology
Educational technology and computing
Health equity
Allergy
Peripheral nervous system
Cancer diagnosis
Medical genetics (excl. cancer genetics)
Major global burdens of disease
Multimorbidity
General practice

Research Objectives

Evaluation of health and support services
Clinical health
Evaluation of health outcomes
Public health (excl. specific population health)
Health policy evaluation
Behaviour and health
Injury prevention and control
Diagnosis of human diseases and conditions
Health education and promotion
Health status (incl. wellbeing)
Treatment of human diseases and conditions
Specific population health (excl. Indigenous health)
Preventive medicine
Health related to ageing
Health system performance (incl. effectiveness of programs)
Other health
Disease distribution and transmission (incl. surveillance and response)
Mental health
Nursing
Determinants of health
Other economic framework
Prevention of human diseases and conditions
Provision of health and support services
Allied health therapies (excl. mental health services)
Overweight and obesity
Aboriginal and Torres Strait Islander health system performance
Occupational health
Nutrition
Health surveillance
Inpatient hospital care
Human pain management
Aboriginal and Torres Strait Islander health
Carbon and emissions trading
Aboriginal and Torres Strait Islander health status and outcomes
Disability and functional capacity
Primary care
Health protection and disaster response
Policies and development
Ageing and older people
Road safety
Network systems and services
Residential construction design
Rural and remote area health
Community health care
Mental health services
Information services
Palliative care

Career Best Publications

Research Publications

trips4health: Protocol of a single-blinded randomised controlled trial incentivising adults to use public transport for physical activity gain; Contemporary Clinical Trials Communications
A comprehensive systematic review of data linkage publications on diabetes in Australia; Frontiers in Public Health
A comprehensive systematic review of data linkage publications on diabetes in Australia; Frontiers in Public Health
A comprehensive systematic review of data linkage publications on diabetes in Australia
A critical review of pharmacoeconomic studies of acamprosate; Alcohol and Alcoholism
A decision tree model for the implementation of a safety strategy in the horse-racing industry; Injury Prevention
A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension; Current Medical Research and Opinion
A head-to-head comparison of the EQ-5D-5L and AQoL-8D multi-attribute utility instruments in patients who have previously undergone bariatric surgery; The Patient
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA; Nephrology, Dialysis and Transplantation
A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease; Current Medical Research and Opinion
A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality; PL o S One
A mixed-methods study of the demographic and behavioural correlates of walking to a more distant bus stop; Transportation Research Interdisciplinary Perspectives
A multivariate logistic regression equation to screen for diabetes: response to Tabaei and Herman; Diabetes Care
A new model of care and in-house general practitioners for residential aged care facilities: a stepped wedge, cluster randomised trial; Medical Journal of Australia
A novel method for calculating prevalence of multiple sclerosis in Australia; Multiple Sclerosis
A patient-level model to estimate lifetime health outcomes of patients with type 1 diabetes; Diabetes Care
A qualitative investigation of the health economic impacts of bariatric surgery for obesity and implications for improved practice in health economics; Health Economics
A Randomised Controlled Trial of YOGa and Strengthening Exercise for Knee OsteoArthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial); Journal of Functional Morphology and Kinesiology
A sub-group analysis of the Australian Multiple Sclerosis Longitudinal Study (AMSLS) assessing costs and utility in Primary Progressive Multiple Sclerosis (PPMS) patients
A systematic review and meta-analysis of health state utility values for osteoarthritis-related conditions; Arthritis Care & Research
A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions; Osteoporosis International
A systematic review and narrative synthesis of health economic evaluations of Hepatocellular Carcinoma (HCC) screening strategies; Value in Health
A systematic review and narrative synthesis of health economic studies conducted for hereditary haemochromatosis; Applied Health Economics and Health Policy
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury; Expert Review of Pharmacoeconomics and Outcomes Research
A systematic review of cost-of-illness studies of multimorbidity; Applied Health Economics and Health Policy
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures; Osteoporosis International
A systematic review of the evolution of health-economic evaluation models of osteoarthritis; Arthritis Care & Research
Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting; Current Medical Research and Opinion
Acceptability and perceived feasibility of strategies to increase public transport use for physical activity gain - a mixed methods study; Health Promotion Journal of Australia
Accident rates amongst regular bicycle riders in Tasmania, Australia; Accident Analysis and Prevention
Accuracy of coded cause of death data: a study based on primary liver cancer; Tasman Medical Journal
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): A randomised controlled trial; BMJ Open
An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy; Value in Health
An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK; Current Medical Research and Opinion
An Economic Evaluation of Irbesartan in the Treatment of Patients with Type 2 Diabetes, Hypertension and Nephropathy: Cost-Effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French Settings; Nephrology, Dialysis and Transplantation
An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting; Journal of Human Hypertension
An exploratory study of long-term publicly waitlisted bariatric surgery patients’ quality of life before and 1 year after bariatric surgery, and considerations for healthcare planners; PharmacoEconomics Open
An exploratory study: a head-to-head comparison of the EQ5D-5L and AQoL-8D for long-term publicly waitlisted bariatric surgery patients before and 3 months after bariatric surgery; PharmacoEconomics - Open
Annual transition probabilities of overweight and obesity in older adults: evidence from World Health Organization Study on global AGEing and adult health; Social Science and Medicine
Applying some UK Prospective Diabetes Study results to Switzerland: The cost-effectiveness of intensive glycemic control with metformin versus conventional control in overweight patients with type 2 diabetes; Schweizerische Medizinische Wochenschrift
Assessing equity in benefit distribution of government health subsidy in 2012 across East China: benefit incidence analysis; International Journal for Equity in Health
Assessing health-related quality-of-life in Australian Multiple Sclerosis Longitudinal Study participants using six multi-attribute utility instruments: implications for healthcare decision-making
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia; Multiple Sclerosis
Assessment and management of chronic respiratory conditions in frail older adults
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D; Quality of life research
Association between fire smoke fine particulate matter and asthma-related outcomes: systematic review and meta-analysis; Environmental Research
Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians; Quality of Life Research
Association between knee symptoms, change in knee symptoms over 6–9 years, and SF-6D health state utility among middle-aged Australians
Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: A cross-sectional study; Multiple Sclerosis and Related Disorders
Australian insurance costs of jockeys injured in a race-day fall; Occupational Medicine
Bariatric surgery is a cost-saving treatment for obesity – a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery; Obesity Reviews
Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting; International Journal of Clinical Practice
Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis; Journal of Neurology
Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data; Multiple Sclerosis Journal
Characteristics associated with willingness to walk further than necessary to the bus stop: Insights for public transport-related physical activity; Journal of Transport and Health
Characteristics of, and insurance payments for, injuries to cyclists in Tasmania, 1990-2010; Accident Analysis & Prevention
Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment; Archives of Osteoporosis
Climate Change, Wildfires, Heatwaves and Health Impacts in Australia; Extreme Weather Events and Human Health
Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy; Deutsche Medizinische Wochenschrift
Comment on: Bariatric surgery is expensive but improves co-morbidity: 5-year assessment of patients with obesity and type 2 diabetes; British Journal of Surgery
Commentary: Intensive glucose control is more costly than conventional treatment but also has more benefits for people with type-2 diabetes; Evidence - Based Healthcare and Public Health
Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting; Current Medical Research and Opinion
Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis; Multiple Sclerosis Journal
Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms; Journal of Neurology
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study; European Journal of Neurology
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes; Current Medical Research and Opinion
Comparison of learning outcomes for teaching focused cardiac ultrasound to physicians: a supervised human model course versus an eLearning guided self- directed simulator course; Journal of Critical Care
Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting; Diabetes Care
Computer modeling of diabetes and its complications: a report on the fifth Mount Hood challenge meeting; Value in Health
Computer modeling of diabetes and its transparency: a report on the Eighth Mount Hood Challenge; Value in Health
Construct validity of SF-6D health state utility values in an employed population; Quality of Life Research
Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia; Pharmacoeconomics
Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis; Primary Care Diabetes
Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes; Diabetes & Metabolism
Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand; Value in Health
Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH; Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research
Cost-effectiveness of CSII - Response (Response to the letter by Philip Home); Diabetic Medicine
Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials; Current Medical Research and Opinion
Cost-effectiveness of diabetes case management for low-income populations; Health Services Research
Cost-effectiveness of different population screening strategies for hereditary haemochromatosis in Australia; Applied Health Economics and Health Policy
Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease; Diabetes Care
Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA; Value in Health
Cost-effectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective; Nefrologia
Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study; Current Medical Research and Opinion
Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study; Diabetes Care
Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective; Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy
Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies; Nephrology, Dialysis and Transplantation
Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence; Patient Preference and Adherence
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study; Osteoporosis International
Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes; Current Medical Research and Opinion
Cost-utility analysis of cinacalcet in addition to standard of care in the UK; Nephrology, Dialysis and Transplantation
Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study; Australian Health Review
Costs of major complications in people with and without diabetes in Tasmania, Australia; Australian Health Review
Costs of major complications in people with and without diabetes in Tasmania, Australia; European association for the study of diabetes (EASD) 58th
Counting the cost of dementia-related hospital admissions: a regional investigation; Australasian Journal on Ageing
Counting the costs of overweight and obesity: modeling clinical and cost outcomes; Current Medical Research and Opinion
Cross-sectional and temporal differences in health-related quality of life of people with and without osteoarthritis: a 10-year prospective study; Rheumatology
CU3 – Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis; Value in Health
Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy; Current Medical Research and Opinion
Dementia tsunami in aged care: can students improve residents' quality of life?; The 46th Australian Association of Gerontology National Conference
Depression in working adults: comparing the costs and health outcomes of working when ill; PLoS ONE
Development and use of prediction models for classification of cardiovascular risk of remote Indigenous Australians; Heart Lung and Circulation
Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis; Osteoporosis International
Development of a life expectancy table for individuals with type 1 diabetes; Diabetologia
Development of the Workplace Health Savings Calculator: a practical tool to measure economic impact from reduced absenteeism and staff turnover in workplace health promotion; BMC Research Notes
Did expansion of health insurance coverage reduce horizontal inequity in healthcare finance? A decomposition analysis for China; BMJ Open
Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review; Obesity Reviews
Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?; Multiple Sclerosis and Related Disorders
Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting ; Swiss Medical Weekly
Economic burden of gastric cancer: A case study of Iran; Cancer Control
Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada; Pharmacoeconomics
Economic Impact of Multiple Sclerosis in 2010: Australian MS Longitudinal Study
Economic implications of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up; Journal of Medical Economics
Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data; Journal of Neurology, Neurosurgery and Psychiatry
Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials; Haemostasis
EPH31 Risk of hospital admission or emergency department presentation due to diabetes complications: A retrospective cohort study in Tasmania, Australia; ISPOR Europe 2022
Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China; Quality of Life Research
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis; Multiple Sclerosis Journal
Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus; Value in Health
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis; Journal of Neurology
Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis; Multiple Sclerosis Journal
Evaluating health related quality of life in older people at risk of osteoporotic fracture: a head-to-head comparison of the EQ-5D-5L and AQoL-6D; Social Indicators Research
Evaluating the ability of economic models of diabetes to simulate new cardiovascular outcomes trials: a report on the Ninth Mount Hood Diabetes Challenge; Value in Health
Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes; Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research
Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents; Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy
Evaluation of health-related quality of life in IPF: A systematic review and meta-analysis
Evaluation of the association between health state utilities and obesity in sub-Saharan Africa: evidence from World Health Organization Study on Global AGEing and Adult Health Wave 2; Value in Health
Exceedances of national air quality standards for particulate matter in Western Australia: sources and health-related impacts; Medical Journal of Australia
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes; Current Medical Research and Opinion
Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype; Multiple Sclerosis Journal
General Practice After Hours Practice Funding: 2014-15 Funding Model
General practice after-hours incentive funding: a rationale for change; Medical Journal of Australia
Gesundheitsoekonomische Auswirkungen der Algodystrophie unter Einbezug von Calcitonin [Health economic effects of calcitonin on algodystrophy]; Managed Care (Switzerland)
Guidelines for computer modeling of diabetes and its complications; Diabetes Care
Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey; International Journal for Equity in Health
Health care, overconsumption and uneconomic growth: a conceptual framework; Social Science and Medicine
Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark; Ugeskrift for Laeger
Health economic consequences of irbesartan treatment of type 2 diabetes patients with nephropathy and hypertension in German; Deutsche Medizinische Wochenschrift
Health Economic Impact of Multiple Sclerosis in Australia in 2017: An analysis of MS Research Australia’s platform – the Australian MS Longitudinal Study (AMSLS)
Health Economic Impact of Multiple Sclerosis in Australia in 2021: An Interim Update of Prevalence, Costs and Cost of Illness from 2017 to 2021
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland; Swiss Medical Weekly
Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis; The European Journal of Health Economics
Health economics analysis of insulin aspart vs. regular human insulin in Type 2 Diabetes patients, based on observational real life evidence from general practices in Germany; Experimental and Clinical Endocrinology & Diabetes
Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria; Kidney International. Supplement
Health economics--what the nephrologist should know; Nephrology, Dialysis and Transplantation
Health impacts of ambient biomass smoke in Tasmania, Australia; International Journal of Environmental Research and Public Health
Health service utilization and direct healthcare costs associated with obesity in older adult population in Ghana; Health Policy and Planning
Health state utilities and high body mass index: evidence from WHO study of global ageing and adult health (SAGE); Value in Health
Health state utilities for economic evaluation of bariatric surgery: a comprehensive systematic review and meta-analysis; Obesity Reviews
Health State Utilities in Dentistry: A Review; Acta Medicinae Dentium Helvetica
Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK; Diabetic Medicine
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis; European Respiratory Review
Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach; Australian Health Review
Healthcare resource utilisation and predictors for critical care unit admissions after primary bariatric surgery in an Australian public hospital setting: an exploratory study using a mixed-methods approach; Australian Health Review
Highly Active Antiretroviral Therapy: Pharmacoeconomic issues in the management of HIV infection; Pharmacoeconomics
Hospitalisation costs of primary liver cancer in Australia: evidence from a data-linkage study; Australian Health Review
Household catastrophic health expenditure and its effective factors: a case of Iran; Cost Effectiveness and Resource Allocation
How consistent is the relationship between improved glucose control and modelled health outcomes for people with type 2 diabetes mellitus? a systematic review; PharmacoEconomics
Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model; Current Medical Research and Opinion
Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana; BMJ Global Health
Impact of remoteness on patient outcomes for people with multiple sclerosis in Australia; Multiple Sclerosis and Related Disorders
Improving equity in health care financing in China during the progression towards Universal Health Coverage; BMC Health Services Research
Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets; International Journal of Clinical Practice
Improving the availability and efficiency of appropriate urgent service provision in Tasmania: Interim evaluation of the GP Assist and the Tasmanian General Practice After-Hours Incentive Funding Model 2014-15
Incentivising public transport use for physical activity gain: process evaluation of the COVID-19 disrupted trips4health randomised controlled trial; The International Journal of Behavioral Nutrition and Physical Activity
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia; Respirology
Increased clinical and economic advantage of proteinuric screening and intervention (PROSIT project) in type 2 diabetics; Deutsche Medizinische Wochenschrift
Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide; Australian and New Zealand Journal of Public Health
Incremental healthcare expenditure attributable to diabetes mellitus: A cost of illness study in Tasmania, Australia; Diabetic Medicine
Incremental healthcare expenditure attributable to diabetes mellitus: a cost of illness study in Tasmania, Australia; Diabetic Medicine
Insulin pumps: more consultation was needed; BMJ
Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US; Diabetes Obesity & Metabolism
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom; Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy
International Diabetes Federation: a consensus on Type 2 diabetes prevention; Diabetic Medicine
Investigating health-related quality of life impacts for participants of the Australian MS Longitudinal Study using the new EQ-5D-5L Psychosocial instrument
Investigating the costs of major and minor cycling crashes in Tasmania, Australia; Australian and New Zealand Journal of Public Health
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria; Kidney International
Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis; International Journal of Clinical Practice
Is greater public transport use associated with higher levels of physical activity in a regional setting? Findings from a pilot study; Pilot and Feasibility Studies
Knowledge translation in the international MS community: an evaluation of the Understanding Multiple Sclerosis free online course
Lead Support Coordinator Service (LSCS) Evaluation Report
Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting; Current Medical Research and Opinion
Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive; Value in Health
Long-term inpatient hospital utilisation and costs (2007-2008 to 2015-2016) for publicly waitlisted bariatric surgery patients in an Australian public hospital system based on Australia's activity-based funding model; PharmacoEconomics - Open
Low Molecular Weight Heparin for Prevention of Thromboembolism in General Surgery: A Meta-Analysis of Randomized Clinical Trials with Low Molecular Weight Heparin, Unfractionated Heparin, and Warfarin; Haemostasis
Maternal choices and preferences for screening strategies of gestational diabetes mellitus: an exploratory study using discrete choice experiment; Frontiers in Public Health
Measuring Hypertension Progression With Transition Probabilities: Estimates From the WHO SAGE Longitudinal Study; Frontiers in Public Health
Measuring the health-related quality of life in Australians with Multiple Sclerosis using the Assessment of Quality of Life-8-Dimension (AQoL-8D) multi-attribute utility instrument; Multiple Sclerosis and Related Disorders
Meta-analysis in oral health care; Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Modeling the impact of adjustable gastric banding on survival in patients with morbid obesity; Obesity Research
Modeling the socioeconomic impact of osteoporosis-related hip fractures in Switzerland; Osteoporosis International
Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes; Pharmacoeconomics
Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: evidence from Australia; Multiple Sclerosis Journal
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis; ERJ Open Research
Motivations for Seeking Bariatric Surgery: The Importance of Health Professionals and Social Networks; Bariatric Surgical Practice and Patient Care
Multimorbidity and Health Care Service Utilization in the Australian Workforce; Journal of Occupational and Environmental Medicine
Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL; Health and Quality of Life Outcomes
New aspects in health economic studies of prevention and treatment of osteoporosis; Expert Review of Pharmacoeconomics & Outcomes Research
Outline of a diabetes disease management model: principles and applications; Diabetes Research and Clinical Practice
Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries; Current Medical Research and Opinion
P43 The economic burden of idiopathic pulmonary fibrosis in Australia; ISPOR 2022 Conference
P50 Comparison of the EQ-5D-5L and Aqol-8D in a cohort of people with idiopathic pulmonary fibrosis in Australia; ISPOR 2022 Conference
P55 Creating a web-based interactive map visualising the geographic variations of the burden of Diabetes to inform policymaking: an example from Tasmania, Australia; ISPOR Europe 2022
PCP4 A qualitative investigation of information asymmetry for obesity surgery: Diversity of patient experiences in the information age and demand-induced supply; Value in Health
Pilot multi-centre randomised trial of the impact of pre-operative focused cardiac ultrasound on mortality and morbidity in patients having surgery for femoral neck fractures (ECHONOF-2 pilot); Anaesthesia
PND10 – Cost-Effectiveness of Population Screening for Haemochromatosis In Australia: A State-Transition Model; Value in Health
PND13 – Assessing Health-State Utility Values in Australian People with Multiple Sclerosis; Value in Health
PND9 – An Australian National Cost of Illness Study For Hereditary Haemochromatosis; Value in Health
Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011-13 Australian Health Survey; Australian Health Review
Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia; Health Economics
Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model; PharmacoEconomics - Open
Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial; Journal of Physiotherapy
Prevalence of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?; BMC Public Health
Prevention of T2DM: health economics; Diapedia. The living textbook of diabetes.
PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events - economic implications?; British Journal of Diabetes and Vascular Disease
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK; Diabetic Medicine
Projected worldwide disease burden from giant cell arteritis by 2050; Journal of Rheumatology
Projection of osteoporosis-related fractures and costs in China: 2010-2050; Osteoporosis International
Protocol for a systematic review and meta-analysis of minimal important differences for generic multiattribute utility instruments; BMJ Open
PSY15 A unique opportunity to assess quality-of-life changes in long-term waitlisted bariatric surgery patients using the EQ-5D-5L and AQOL-8D multi-attribute utility instruments before and three months after bariatric surgery: an exploratory study; Value in Health
PSY33 A Cost-Outcome Study: A real-world investigation of long-term inpatient hospital utilisation and costs for a retrospective cohort of bariatric surgery patients in an Australian public hospital system based on Australia's activity based funding model; Value in Health
Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study; BMCNephrology
Psychosocial factors in chronic kidney disease: 2 year follow-up of pilot participants; ANZSN 50th Annual Scientific Meeting
Quality of life improves more for people who receive proactive absolute
Quality of life utility values for hereditary haemochromatosis in Australia; Health and Quality of Life Outcomes
Rapidly increasing prevalence of overweight and obesity in older Ghanaian adults from 2007-2015: evidence from WHO-SAGE Waves 1 & 2; PLoS One
Rates and reasons for emergency department presentations of patients wait-listed for public bariatric surgery in Tasmania, Australia; Obesity Research and Clinical Practice
Re-operations after Secondary Bariatric Surgery: a Systematic Review; Obesity Surgery
Recent trends in life expectancy for people with type 1 diabetes in Sweden; Diabetologia
Recent trends in pirfenidone and nintedanib utilisation for idiopathic pulmonary fibrosis in Australia; Australian Health Review
Residents with mild cognitive decline and family members report health students 'enhance capacity of care' and bring 'a new breath of life' in two aged care facilities in Tasmania; Health Expectations
Residual lifetime and 10 year absolute risks of osteoporotic fractures in Chinese men and women; Current Medical Research and Opinion
Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system; The European Journal of Health Economics
Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain; Current Medical Research and Opinion
Risk factors for leaving employment due to multiple sclerosis and changes in risk over the past decades: using competing risk survival analysis; Multiple Sclerosis Journal
Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model; Osteoporosis International
Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study; Osteoporosis International
Severe hypoglycemia and mortality after cardiovascular events for Type 1 diabetic patients in Sweden; Diabetes Care
SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis; Quality of Life Research
Smoke health costs and the calculus for wildfires fuel management: a modelling study; The Lancet Planetary Health
Socio-demographic, behavioural and health-related characteristics associated with active commuting in a regional Australian state: evidence from the 2016 Tasmanian Population Health Survey; Health Promotion Journal of Australia
Some principles of cost-effectiveness analysis in dentistry; Acta Medicinae Dentium Helvetica
Study protocol for a multicentre, controlled non-randomised trial: benefits of exercise physiology services for type 2 diabetes (BEST); BMJ Open
Sublingual Immunotherapy in Allergic Rhinitis and Asthma: A Review of Recent Clinical Evidence; Journal of Applied Research: in Clinical and Experimental Therapeutics
Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia; Cancer Epidemiology
Tasmanian After-Hours Primary Care Service Innovations: A Report in Three Parts
Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings
The associations of multimorbidity with health-related productivity loss in a large and diverse public sector setting: A cross-sectional survey; Journal of Occupational and Environmental Medicine
The challenge of transparency and validation in health economic decision modelling: a view from Mount Hood; PharmacoEconomics
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making; Current Medical Research and Opinion
The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran; Cost Effectiveness and Resource Allocation
The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr; Diabetic Medicine
The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective; Diabetologia: Clinical and Experimental Diabetes and Metabolism
The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective; Monaldi Archives for Chest Disease
The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective (letter); Monaldi Archives for Chest Disease
The cost-effectiveness of interventions in diabetes: A review of published economic evaluations in the UK setting, with an eye on the future
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy; Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy
The Economic Burden of Deep Vein Thrombosis Sequelae: A Cost of Illness Analysis for Germany; Gesundheitsoekonomie und Qualitaetsmanagement
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study; The European Journal of Health Economics
The economic impact of multiple sclerosis in Australia in 2010; Multiple Sclerosis
The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis; Multiple Sclerosis
The impact of comorbidities on health-related quality of life of people with osteoarthritis over 10 years; Rheumatology
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia; Quality of Life Research
The impact of increasing severity of hereditary haemochromatosis on health state utility values; Value in Health
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia; Multiple Sclerosis Journal
The impact of the COVID-19 pandemic and lockdowns on the health-related quality of life of people living with multiple sclerosis in Australia
The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: results from updated and detailed data on types of costs; Multiple Sclerosis and Related Disorders
The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate; Alcohol and Alcoholism
The Mt. Hood Challenge: cross-testing two diabetes simulation models; Diabetes Research and Clinical Practice
The need for an improved evidence base to inform the health care decision-making process; JAMA Surgery
The new Australian after-hours general practice incentive payment mechanism: equity for rural general practice?; Health Policy
The relationship between return on investment and quality of study methodology in workplace health promotion programs; American Journal of Health Promotion
The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument; Quality of Life Research
The role of intergenerational educational mobility and household wealth in adult obesity: evidence from wave 2 of the World Health Organization's study on global AGEing and adult health; PLoS ONE
The support needs of patients waiting for publicly funded bariatric surgery - implications for health service planners; Clinical Obesity
Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States; Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research
Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021; Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2021
Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States; Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy
Unprecedented health costs of smoke-related PM_2.5 from the 2019–20 Australian megafires; Nature Sustainability
Unprecedented smoke-related health burden associated with the 2019-20 bushfires in eastern Australia; Medical Journal of Australia
Uptake of and expenditure on direct-acting antiviral agents for Hepatitis C treatment in Australia; Applied Health Economics and Health Policy
Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels; Journal of Neurology, Neurosurgery and Psychiatry
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand; The European Journal of Health Economics
Validation of 0-10 MS symptom scores in the Australian multiple sclerosis longitudinal study; Multiple Sclerosis and Related Disorders
Validation of the CORE Diabetes Model against epidemiological and clinical studies; Current Medical Research and Opinion
Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia; Quality of Life Research
What are the health and socioeconomic impacts of allergic respiratory disease in Tasmania?; Australian Health Review
What are the support experiences and needs of patients who have received bariatric surgery?; Health Expectations
What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model; Current Medical Research and Opinion
What Value GP Assist? The comparative benefits of, and satisfaction with GP Assist in Residential Aged Care Facilities and General Practice in Rural and Urban Tasmania
Who discusses reaching a healthy weight with a general practitioner? Findings from the 2014-2015 Australian National Health Survey; Obesity Research and Clinical Practice
Workplace injuries in thoroughbred racing: An analysis of insurance payments and injuries amongst jockeys in Australia from 2002 to 2010; Animals

Research Projects

A randomised clinical trial of a digital self-management package for people with Interstitial Lung Disease (the REBUILD-SM trial); Medical Research Future Fund (MRFF)
Ambulatory oxygen for interstitial lung disease; National Health & Medical Research Council (NHMRC)
ANCHOR Project: heAlth ecoNomics and epidemiology of myalgiC encephalomyelitis/ chronic fatigue syndrome; Medical Research Future Fund (MRFF)
Association between bush fire-smoke/wood-smoke and hospital usage in Tasmania; Royal Hobart Hospital Research Foundation (RHHRF)
AusGo-SHEMO..Let's Go! Australian Gold Standard Health Economics Model of Osteoporosis; National Health & Medical Research Council (NHMRC)
Bariatric surgery in Tasmania: investigating health service use, costs, patient outcomes and policy options; National Health & Medical Research Council (NHMRC)
Bariatric surgery in Tasmanian public hospitals: investigating health service use, costs, and policy options; Royal Hobart Hospital Research Foundation (RHHRF)
Centre of Research Excellence in Pulmonary Fibrosis; National Health & Medical Research Council (NHMRC)
Clinical Redesign of respiratory pathways in residential aged care; University of Tasmania (UTAS)
Comparison of learning focused cardiac ultrasound between self-directed/simulator and instructor/live model teaching; Australian and New Zealand College of Anaesthetists (ANZCA)
CRE for Pulmonary Fibrosis - towards individualised care; National Health & Medical Research Council (NHMRC)
Dementia-related presentations at the Royal Hobart Hospital - A pilot program for redesigning state-wide clinical care pathways involving Tasmanian residential aged care facilities (RACFs) and their c; Royal Hobart Hospital Research Foundation (RHHRF)
DEVA MS: DEvelopment and VAlidation of a cost effectiveness simulation model for Multiple Sclerosis and implications for health policy; Multiple Sclerosis Australia (MSA)
Development and validation of a health policy simulation model for type 1 diabetes; National Health & Medical Research Council (NHMRC)
Does treating multiple sclerosis alter long-term disease outcomes? a natural history study; Multiple Sclerosis Australia (MSA)
Eliminating hepatitis B in remote Indigenous settings: generating health economic evidence; National Health & Medical Research Council (NHMRC)
Epidemiology and economic impact of injuries to jockeys in the thoroughbred racing industry; WorkCover Tasmania (WCT)
Evaluation of the Tasmanian Elective Surgery Panel Project; Royal Hobart Hospital Research Foundation (RHHRF)
Guidance of Heart Failure Management Programs by Risk Assessment; National Health & Medical Research Council (NHMRC)
Health by Stealth: Increasing Physical Activity through Active Travel in Tasmania; National Health & Medical Research Council (NHMRC)
Improving care through imbedding general practitioners within residential aged care facilities; Bupa Foundation (Australia) Limited (Bupa (Aust.))
Improving health and wellbeing in the Tasmanian State Service workforce; National Health & Medical Research Council (NHMRC)
Improving prevention and early intervention for type 2 diabetes in Tasmania; University of Tasmania (UTAS)
InforMS - an electronic patient-driven health care model with digital biomarker monitoring that improves the clinical care of people with MS; National Health & Medical Research Council (NHMRC)
Look before you leap: how transthoracic echocardiography before fractured neck of femur saves lives in frail older people. The proposed pragmatic ECHONOF III Trial; Medical Research Future Fund (MRFF)
Lung cancer screening in Tasmania; Royal Hobart Hospital Research Foundation (RHHRF)
NAFLD- screen (Non-alcoholic fatty liver disease: prevalence and screening for type 2 diabetes patients) ; Royal Hobart Hospital Research Foundation (RHHRF)
Sustained Effective Oral Care to Significantly Reduce Aspiration Pneumonia experienced by Adults with Dementia in Residential Care; Dementia Collaborative Research Centre (DCRC)
The health economic impacts of residential fires on the Tasmanian public healthcare system 2010 to 2020 using a mixed-methods approach; Royal Hobart Hospital Research Foundation (RHHRF)
The Menzies Multiple Sclerosis Flagship Program; Medical Research Future Fund (MRFF)
The Royal Hobart Hospital's innovative Rapid Access Chest Pain Clinic (RACPC): A health economic evaluation of patient, RHH and community benefits; Royal Hobart Hospital Research Foundation (RHHRF)
The value of osteoporosis interventions evaluating the cost effectiveness and incorporating patients preference; National Health & Medical Research Council (NHMRC)
Understanding the economic burden of climate-related extreme events: A framework to support future planning and decision making in the health care sector; Department of Premier and Cabinet (DPAC)
Using data linkage to estimate the burden of diabetes in Tasmania; Royal Hobart Hospital Research Foundation (RHHRF)
What is the economic impact of allergic respiratory disease in Tasmania?; University of Tasmania (UTAS)
5th Mount Hood Challenge Conference Malmo Sweden 18-19 Sept 2011
Australian MS Longitudinal study
Economic Impact of MS - 2007 cost of illness data AMSLS - PPMS sub-analysis
Economic Impact of MS in Australia Report (2018)
Evaluation of new Tasmanian general practice after hours incentive funding model and the value for money of GP Assist
Evaluation of the extended School Lunch Pilot
GP Assist Evaluation
Impact of remoteness on MS outcomes
Lead Support Coordinator Service (LSCS) Evaluation
PISTACHIO - The Primary Trauma Care Course Impact and Outcome study in Vietnam
Prevalence and economic cost of multiple sclerosis in Australia 2022
Prevalence, incidence, risk profiles, and health impacts of residential fires in Tasmania 2010-2020
Provision of Health Economics consultancy service to develop a new Tasmanian GP After Hours Incentive Funding Model(s)
Reducing the Burden of Liver Cancer for Tasmanians
SON3509188 Panel for services relating to health evidence, advice and methods
SON3599169 Tender - Panel: Health Technology Assessment, Research Support and Other Services

Research Candidate Supervision

Health Economics of Haemochromatosis, with a Focus on the Australian Setting
Health Economics of Osteoperosis-Related Fractures in Australia
Likely Impact of Coming Changes to Health Funding on New South Wales Hospitals
Managing Obesity in Tasmania
Reducing the social, personal and public burden of obesity- an economic and epidemiological analysis
Revisional Bariatric Surgery- Predictors, Outcomes and Economic Impact on Tasmanian Healthcare
The Economic Case For Workplace Health Promotion in the Tasmanian State Service- the Partnering Healthy@Work Project
The impact of job losses on the physical and mental health of Tasmanians